Thiogenesis Announces DTC Eligibility in the U.S. and Other Updates

newsfileNov 28 22:00

Thiogenesis Announces Important Core Patent Allowed in Europe

newsfileNov 4 22:00

Thiogenesis Announces Investor Relations Engagement

newsfileSep 27 22:00

Thiogenesis Proposes Phase 2 Trial to Evaluate Its NASH Treatment

MT NewswiresAug 20 23:02

Thiogenesis Announces Collaboration and Updates on Pediatric NASH Clinical Program

newsfileAug 20 21:00

Thiogenesis Announces Leigh Syndrome Clinical Program

newsfileJul 18 21:00